Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
International Journal of Radiation Oncology, Biology, Physics|February 23, 2010
Quantitative ultrasonic evaluation of radiation-induced late tissue toxicity: pilot study of breast cancer radiotherapyTian Liu, Jun Zhou, Emi J Yoshida, et al.Brachytherapy|May 20, 2017
A national survey of HDR source knowledge among practicing radiation oncologists and residents: Establishing a willingness-to-pay threshold for cobalt-60 usageRaymond Mailhot Vega, Wesley Talcott, Omar Ishaq, et al.Brachytherapy|April 6, 2004
Ultrasonic spectrum-analysis and neural-network classification as a basis for ultrasonic imaging to target brachytherapy of prostate cancerErnest J Feleppa, Ronald D Ennis, Peter B Schiff, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 18, 2026
Intra-fraction target motion during MR-guided prostate stereotactic body radiotherapy: the importance of adaptive planning and real-time motion managementMichael J Zelefsky, Ting Chen, Ryan D Walters, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 23, 2023
Dose prescription and reporting in stereotactic body radiotherapy: A multi-institutional studyIndra J Das, Poonam Yadav, Aaron D Andersen, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 9, 2026
Multiparametric MRI assessment of 6-month Post-Treatment response following Real-Time adaptive stereotactic body radiotherapy for prostate cancer: Correlation with Post-Treatment PSA kineticsSungmin Woo, Anton S Becker, Hebert Alberto Vargas, et al.Journal of Contemporary Brachytherapy|January 22, 2019
Cost in perspective: direct assessment of American market acceptability of Co-60 in gynecologic high-dose-rate brachytherapy and contrast with experience abroadRaymond B Mailhot Vega, David Barbee, Wesley Talcott, et al.JAMA Oncology|June 1, 2018
Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 TrialRobert D Timmerman, Rebecca Paulus, Harvey I Pass, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2019
Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck CancerLoren K Mell, Hanjie Shen, Phuc Felix Nguyen-Tân, et al.European Urology|April 7, 2026
Pembrolizumab in Combination With Gemcitabine and Concurrent Hypofractionated Radiation Therapy as Bladder-sparing Treatment for Muscle-invasive Urothelial Cancer of the Bladder: A Multicenter Phase 2 TrialMinas P Economides, Peter H O'Donnell, Ajjai S Alva, et al.Pageof 5